Journal article
Lipid degradation promotes prostate cancer cell survival.
- Abstract:
-
Prostate cancer is the most common male cancer and androgen receptor (AR) is the major driver of the disease. Here we show that Enoyl-CoA delta isomerase 2 (ECI2) is a novel AR-target that promotes prostate cancer cell survival. Increased ECI2 expression predicts mortality in prostate cancer patients (p = 0.0086). ECI2 encodes for an enzyme involved in lipid metabolism, and we use multiple metabolite profiling platforms and RNA-seq to show that inhibition of ECI2 expression leads to decreased...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 3.6MB)
-
- Publisher copy:
- 10.18632/oncotarget.16123
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Norwegian Cancer Society
More from this funder
Southern and Eastern Norway Regional Health Authority
More from this funder
Norwegian Research Council
More from this funder
Movember Prostate Cancer Centre of Excellence.
More from this funder
Expand funders...
Bibliographic Details
- Publisher:
- Impact Journals Publisher's website
- Journal:
- Oncotarget Journal website
- Volume:
- 8
- Issue:
- 24
- Pages:
- 38264-38275
- Publication date:
- 2017-03-01
- Acceptance date:
- 2017-03-01
- DOI:
- EISSN:
-
1949-2553
- ISSN:
-
1949-2553
- Pmid:
-
28415728
- Source identifiers:
-
817469
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:817469
- UUID:
-
uuid:bd91bd87-f47a-41d5-8e80-2c032d6aff16
- Local pid:
- pubs:817469
- Deposit date:
- 2018-01-11
Terms of use
- Copyright holder:
- Itkonen et al
- Copyright date:
- 2017
- Notes:
- Copyright: Harri M. Itkonen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record